BioSynthema Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
BioSynthema General Information
Description
Developer of unique pharmaceuticals intended to target cell surface receptors overexpressed in cancer cells. The company develops technology that makes specific tumors highly visible using diagnostic imaging methods, thereby enabling clients with earlier and more accurate diagnosis of cancer and treatment of neuroendocrine tumors.
Contact Information
Website
www.biosynthema.com(Operating Subsidiary)
Corporate Office
- 4041 Forest Park Avenue
- Saint Louis, MO 63108
- United States
Corporate Office
- 4041 Forest Park Avenue
- Saint Louis, MO 63108
- United States
BioSynthema Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BioSynthema FAQs
-
When was BioSynthema founded?
BioSynthema was founded in 2001.
-
Where is BioSynthema headquartered?
BioSynthema is headquartered in Saint Louis, MO.
-
What industry is BioSynthema in?
BioSynthema’s primary industry is Drug Discovery.
-
Is BioSynthema a private or public company?
BioSynthema is a Private company.
-
What is BioSynthema’s current revenue?
The current revenue for BioSynthema is .
-
When was BioSynthema acquired?
BioSynthema was acquired on 01-May-2010.
-
Who acquired BioSynthema?
BioSynthema was acquired by Advanced Accelerator Applications.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process